LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Tim Hein: New VP of Sales at Paradigm Spine
Company News

Tim Hein: New VP of Sales at Paradigm Spine

April 18, 2018 1 min read Premium comments

Advertisement

Tim Hein: New VP of Sales at Paradigm Spine
Tim Hein / Courtesy of Paradigm Spine
#coflex#paradigmspineSecondary#timhein

Paradigm Spine, LLC has a new leader to guide U.S. sales of the company’s lead product—coflex Interlaminar Stabilization.

Tim Hein, a 20-year veteran of the medical device industry, has prior leadership experience at Zimmer Biomet Spine, LDR Spine, Medtronic, DePuy Spine, and Ethicon Endo-Surgery. Hein earned his B.S. in Engineering from the United States Military Academy at West Point and his MBA from Pacific Lutheran University.

“With published datasets of long-term Level 1 evidence from two prospective, randomized, controlled clinical studies, comparing coflex versus decompression plus fusion and more recently coflex versus decompression alone, we have entered a major inflection point for the company where we can conclusively show that coflex demonstrates composite clinical success for patients with spinal stenosis,” said Marc Viscogliosi, chairman and CEO of Paradigm Spine, in the March 26, 2018 news release.

“Based on this, and the recent NASS [North American Spine Society] Coverage Recommendation for coflex for interlaminar stabilization, it becomes of paramount importance to strengthen both our technology development and sales and marketing teams to help educate surgeons, practices, patients, their families and the broader spine community on coflex as the motion-preserving lumbar option.”

Tim Hein told OTW, “The combination of innovative technology, market creation sales leadership experiences developed throughout my medical device career at Ethicon Endo-Surgery, Kyphon and LDR Spine. In terms of pure leadership, my experience as an Army officer was invaluable.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy